ENTITY

Leads Biolabs (9887 HK)

56
Analysis
Health Care • China
Leads Biolabs is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies for oncology, autoimmune, and other severe diseases, focusing on unmet medical needs. The company leverages proprietary technology platforms to advance a pipeline of drug candidates, including bispecific antibodies and fusion proteins. Founded in 2012, Leads Biolabs is headquartered in Nanjing, China.
more
bullish•Leads Biolabs
•08 Aug 2026 04:34

Primer: Leads Biolabs (9887 HK) - Aug 2026

Leads Biolabs is a clinical-stage biotechnology firm with a robust and differentiated pipeline of 14 drug candidates, primarily focused on...

Share
x